Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition).
Zeng XT, Jin YH, Liu TZ, Chen FM, Ding DG, Fu M, Gu XQ, Han BM, Huang X, Hou Z, Hu WL, Kang XL, Li GH, Li JX, Li PJ, Liang CZ, Liu XH, Liu ZY, Liu CX, Liu JM, Luo GH, Luo Y, Qin WJ, Qiu JH, Qiu JX, Shang XJ, Shi BK, Sun F, Tian GX, Tian Y, Wang F, Wang F, Wang YH, Wang YJ, Wang ZP, Wang Z, Wei Q, Xiao MH, Xu WH, Yi FX, Zhu CY, Zhuang QY, Zhou LQ, Zou XF, Xing NZ, He DL, Wang XH; Chinese Urological Doctor Association (CUDA); Urological Association of Chinese Research Hospital Association (CRHA-UA); Uro-Health Promotive Association of China International Exchange and Promotive Association for Medical and Health Care (CPAM-UHPA).
Mil Med Res. 2022 Apr 1;9(1):14. doi: 10.1186/s40779-022-00371-6.
Bipolar technology for transurethral prostatectomy.
Ubee SS, Philip J, Nair M.
Expert Rev Med Devices. 2011 Mar;8(2):149-54. doi: 10.1586/erd.10.90.
Comparison of transurethral plasmakinetic and transvesical prostatectomy in treatment of 100-149 mL benign prostatic hyperplasia.
Long Z, Zhang YC, He LY, Zhong KB, Tang YX, Huang K.
Asian J Surg. 2014 Apr;37(2):58-64. doi: 10.1016/j.asjsur.2013.04.006. Epub 2013 May 28.
[Transurethral bipolar plasmakinetic prostatectomy for benign prostatic hyperplasia in high-risk and senior patients in China: a systematic review and meta-analysis].
Zhang ZY, Zhao MJ, Hong BA, Ma LL, Jin YH, Zeng XT, Gong K.
Zhonghua Yi Xue Za Zhi. 2019 Mar 12;99(10):778-782. doi: 10.3760/cma.j.issn.0376-2491.2019.10.015.
Transurethral resection of prostate with plasmakinetic energy: 100 months results of a prospective randomized trial.
Muslumanoglu AY, Yuruk E, Binbay M, Akman T.
BJU Int. 2012 Aug;110(4):546-9. doi: 10.1111/j.1464-410X.2011.10770.x. Epub 2011 Nov 24.
Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: a single center randomized controlled trial.
Del Rosso A, Pace G, Masciovecchio S, Saldutto P, Galatioto GP, Vicentini C.
Int J Urol. 2013 Apr;20(4):399-403. doi: 10.1111/j.1442-2042.2012.03174.x. Epub 2012 Sep 25.
Transurethral plasmakinetic resection versus enucleation for benign prostatic hyperplasia: comparison of intraoperative safety profiles based on endoscopic surgical monitoring system.
Jin Q, Yang EG, Zhang YX, Mi J, Dong ZL, Yang L, Tian JQ, Wang J, Wang ZP.
BMC Urol. 2022 Apr 19;22(1):65. doi: 10.1186/s12894-022-01014-7.
A Preliminary, Multicenter, Prospective and Real World Study on the Hemostasis, Coagulation, and Safety of Hemocoagulase Bothrops Atrox in Patients Undergoing Transurethral Bipolar Plasmakinetic Prostatectomy.
Li BH, Yu ZJ, Wang CY, Zi H, Li XD, Wang XH, Ren XY, Liu TZ, Zheng H.
Front Pharmacol. 2019 Nov 27;10:1426. doi: 10.3389/fphar.2019.01426. eCollection 2019.
Bipolar plasmakinetic transurethral enucleation and resection versus bipolar plasmakinetic transurethral resection for surgically treating large (60 g) prostates: a propensity score-matched analysis with a 3-year follow-up.
Deng W, Chen L, Liu X, Jiang H, Zhou Z, Li Y, Wang G, Fu B.
Minerva Urol Nephrol. 2021 Jun;73(3):376-383. doi: 10.23736/S2724-6051.20.03804-7. Epub 2020 Jun 22.
A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications.
Otaola-Arca H, Álvarez-Ardura M, Molina-Escudero R, Fernández MI, Páez-Borda Á.
Int Braz J Urol. 2021 Jan-Feb;47(1):131-144. doi: 10.1590/S1677-5538.IBJU.2019.0766.
